Sec Form 3 Filing - AK Holding Company, LC @ Clene Inc. - 2020-12-03

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 3
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
AK Holding Company, LC
2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
3200 WEST CLUBHOUSE DRIVE, SUITE 200
3. Date of Earliest Transaction (MM/DD/YY)
12/03/2020
(Street)
LEHI, UT84043
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock ( 1 ) 5,135,676 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Senior Warrant to Purchase Common Stock ( 2 ) $ 1.97 12/30/2020 04/08/2023 Common Stock 160,121 D
Series A Warrant to Purchase Common Stock ( 3 ) $ 1.97 12/30/2020 04/04/2023 Common Stock 864,121 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
AK Holding Company, LC
3200 WEST CLUBHOUSE DRIVE
SUITE 200
LEHI, UT84043
X
Signatures
David Harkness 01/06/2021
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The securities owned by AK Holding Company, LC (including the Warrant and Senior Warrant described below) may also be deemed to be owned by Alan Ashton and Karen Ashton. Mr. and Mrs. Ashton each own 50% of the membership interests in AK Holding Company, LC.
( 2 )Senior Warrant ("Senior Warrant") to purchase Series D Preferred Stock, issued by Clene Nano-Medicine Inc. to AK Holding Company, LC dated April 8, 2013 and currently exercisable for shares of Clene Inc. The Senior Warrant owned by AK Holding Company, LC may also be deemed to be owned by Alan Ashton and Karen Ashton. Mr. and Mrs. Ashton each own 50% of the membership interests in AK Holding Company, LC.
( 3 )Warrant ("Warrant") to purchase Series A Preferred Stock, such warrant issued by Clene Nanomedicine, Inc. to AK Holding Company, LC on April 4, 2013 and currently exercisable for Clene Inc. common stock. The Warrant may also be deemed to be owned by Alan Ashton and Karen Ashton. Mr. and Mrs. Ashton each own 50% of the membership interests in AK Holding Company, LC.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.